Star fund manager Neil Woodford recently revealed the top ten holdings in the new Woodford Equity Income fund.
Now he’s gone one step further and announced the holdings in full on his fund website. Woodford intends that this will be updated every month.
It will come as no surprise that large-cap pharmaceutical stocks are among the favourites. AstraZeneca and GSK are the top two holdings, at 8.3% and 7.1% of the fund respectively. Other big firms from the sector include Roche, Sanofi, Novartis, and Prothena which together make up 9.9% of the portfolio.
As my colleague Ed Bowsher remarked earlier today, Woodford is a big fan of tobacco stocks (not a view that Ed shares). In fact, tobacco makes up over 18% of the portfolio.
He’s also keen on government outsourcers, with G4S, Serco and Capita making up 4.96%, and on traditional utilities – Drax, SSE, and Centrica come in at 4.9% of the portfolio.
Further down the list come quite a few small-cap pharmaceutical and biotech stocks, including ReNeuron, Retroscreen Virology, e-Therapeutics, Oxford Pharmascience, and 4D Pharma.
Biotech is a hot topic at the moment, and my colleague Matthew Partridge recently picked a couple of interesting small-cap biotech stocks that are looking in to the new generation of antibiotics.
And earlier this year in MoneyWeek magazine, he looked at the opportunities available to investors in stem-cell research. If you’re not already a subscriber, get your first four copies free here.
Here’s the full list of the stocks in the Woodford Equity Income Fund.
| 1 | AstraZeneca | Healthcare | 8.3% |
| 2 | GlaxoSmithKline | Healthcare | 7.1% |
| 3 | British American Tobacco | Consumer goods | 6.2% |
| 4 | BT | Telecommunications | 6% |
| 5 | Imperial Tobacco | Consumer goods | 5.3% |
| 6 | Roche | Healthcare | 3.9% |
| 7 | Imperial Innovations | Financials | 3.6% |
| 8 | Reynolds American | Consumer goods | 3.6% |
| 9 | Rolls-Royce | Industrials | 3.5% |
| 10 | Capita | Industrials | 3.4% |
| 11 | Allied Minds | Financials | 2.9% |
| 12 | BAe Systems | Industrials | 2.9% |
| 13 | HSBC | Financials | 2.8% |
| 14 | Sanofi | Healthcare | 2.3% |
| 15 | Legal & General | Financials | 2.1% |
| 16 | Novartis | Healthcare | 2% |
| 17 | Centrica | Utilities | 2% |
| 18 | AA | Consumer services | 1.9% |
| 19 | SSE | Utilities | 1.8% |
| 20 | Reckitt Benckiser | Consumer goods | 1.8% |
| 21 | Philip Morris International | Consumer goods | 1.8% |
| 22 | Prothena | Healthcare | 1.7% |
| 23 | Next | Consumer services | 1.7% |
| 24 | Altria | Consumer goods | 1.3% |
| 25 | Smith & Nephew | Healthcare | 1.3% |
| 26 | BTG | Healthcare | 1.2% |
| 27 | Provident Financial | Financials | 1.1% |
| 28 | Drax | Utilities | 1.1% |
| 29 | Alkermes | Healthcare | 1% |
| 30 | Gagfah | Financials | 1% |
| 31 | G4S | Industrials | 0.97% |
| 32 | RM2 International | Industrials | 0.93% |
| 33 | Redde | Financials | 0.90% |
| 34 | Utilitywise | Industrials | 0.62% |
| 35 | Serco | Industrials | 0.59% |
| 36 | Meggitt | Industrials | 0.59% |
| 37 | Lancashire | Financials | 0.58% |
| 38 | Velocys | Oil & gas | 0.55% |
| 39 | e-Therapeutics | Healthcare | 0.54% |
| 40 | Vernalis | Healthcare | 0.49% |
| 41 | ReNeuron | Healthcare | 0.48% |
| 42 | Cobham | Industrials | 0.48% |
| 43 | Burford Capital | Financials | 0.44% |
| 44 | Catlin | Financials | 0.43% |
| 45 | Benchmark | Healthcare | 0.43% |
| 46 | Amlin | Financials | 0.43% |
| 47 | 4D Pharma | Healthcare | 0.43% |
| 48 | Oxford Pharmascience | Healthcare | 0.35% |
| 49 | Revolymer | Basic materials | 0.31% |
| 50 | Hiscox | Financials | 0.31% |
| 51 | Beazley | Financials | 0.29% |
| 52 | Gigaclear | Telecommunications | 0.29% |
| 53 | Paypoint | Industrials | 0.25% |
| 54 | Homeserve | Industrials | 0.09% |
| 55 | Retroscreen Virology | Healthcare | 0.09% |
| 56 | Xeros | Industrials | 0.07% |
| 57 | NetScientific | Healthcare | 0.05% |
| 58 | IP | Financials | 0.04% |
| 59 | Circassia | Healthcare | 0.03% |
| 60 | Stobart | Industrials | 0.03% |
| 61 | Cranswick | Consumer goods | 0.01% |